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Abstract: Bronchial asthma is classified into three types; type I a ( I a- 1 and I a-
2), type I b, and type II, by clinical symptoms (clinical diagnosis). Asthma is also
classified by clinical findings and examinations (score diagnosis). Both classification
systems show !hat markedly increased proportion of BAL neutrophils and marked
decrease in % V25 value are characteristic of type II, bronchiolar obstruction, asthma.
However, there are some type II asthma patients without BAL neutrophilia. In these
patients, age is higher compared to those with BAL enutrophl ia. Decrease in FEV1.0%
value and decrease in the proportion of BAL Iympocytes and serum IgG level, are not
so remarkable as decrease in those with BAL neutrophilia. It has been suggested that
type II asthma with BAL neutrophilia correlates with suppression of humoral and
cellular immunity, and same type of astma without BAL neutrophilia is in part caused
by aging.
.
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Introduction
It has been well known that airway inflam-
mation is a common feature of bronchial
asthmal-7). In the process of airway inflam-
mation, lymphocytes, neutrophils, eosinophils
and basophils migrate from peripheral blood
into local allergic reaction sites. Among these
cells, roles of activated T cells and
eosinophils have been noted m relation to
late asthmatic redctiona 9). Basophilic cells,
mast cells and basophils, also play an impor-
tant role in triggering events of asthma
attacks. Furthermore, participation of
neutrophils in the onset mechanisms of
asthma has been reported in recent yearslO• ll) •
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Our studies have shown that asthma can be
classified by clinical symptoms (clinical
diagnosis) 12-14). We have also demonstrated
that characteristic of each clinical asthma
type is closely related to clinical examina-
tions such as the proportion of cells in
bronchoalveolar lavage (BAL) fluid. Thus,
bronchial asthma IS also classified by
clinical findings and examinations (score
diagnosis) IS). The results from these studies
have revealed that type IT, bronchiolar ob-
struction, asthma is closely associated with
BAL neutrophilia. However, our recent stud-
ies of asthma have leaded to the results that
there are some type IT asthma patients
without BAL neutrophilia1S). In the present
article, we tried to clarify clincal features of
type IT asthma without BAL neutrophilia
(BALn-), compared to type II asthma with
BAL neutrophilia (BALn+), and to other
asthma types.
Clinical diagnosis
Bronchial asthma is classified into three
types; I a. simple bronchoconstriction type,
lb. bronchoconstriction+hypersecretion type,
and II bronchiolar obstruction type, by
clinical s~:mpyoms12-14). Type la is, further-
more, divided into two subtypes according
to expectoration per day ; type I a-I
(0-49 me) and type I a- 2 (50-99 mR)
(Table 1 )14).
Different proportions of BAL cells are
found in each asthma type. In I b. hyper-
secretion type, increased proportion of BAL
eosinophils are often observedl4, 17), as shown
in Fig. 1. The proportion of BAL eosino-
phils tended to increase as dose of expectora-
tion a day inceasesed. A significant increase
in BAL eosinophils was found in subjects
with expectoration between 50 and 99 me /
Table 1. Asthma classification by clinical
symptoms and signs
Type Clinical symptoms and signs
la. Simple broncho- Patients with symptoms such as
constrictior. wheezing and dyspnea which are
mainly elicited by broncho-
constriction.
This type is divided into two
subtypes according to the amount
of expectoration.
la-l: 0-49 ml/day
1a-2: 50-99 ml/day
lb. Bronchoconstriction Patients with symptoms due to
+hypersecretion hypersecretion (more than 100
ml/day). in addition to broncho-
constriction.
II. Bronchiolar Patients with symptoms mainly
obstruction elicited by bronchiolar obstruction
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Fig. 1. Relationship of amount of expectora-
tion to proportion of eosinophilis in
BAL fluid in patients with bronchial
asthma. a and b : p<O.Ol.
day (p<0.05) and in those with e::pectoration
over 100 mP/day (p<O.Ol) compared with
those expectoration between 30 and 49mP /
day. The proportion of BAL lymphocytes was
the highest in patients with type I a-I and
lowest in those with type IT. There was,
however, no significant difference III the
number of BAL lymphocytes between the
clinical asthma types. The proportion of BAL
neutrophils was significantly higher in pa-
tients with type IT icompared to those with
type I a-I (P<O.OOl), type I a - 2
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%V25 value in each clinical asthma
type. a: p<O.OOl, b : p<0.02, c :
p<O.Ol.
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Fig. 2. Proportion of BAL lymphocytes
( ~) and neutrophils (.) in each Fig. 3.
clinical asthma type. a, b, c : p<
0.001.
No of paints
5
4
Clinical score: from 0 to 4 (type la). from 5 tall (type
Ib, of 12 or mare (type II)
Table 2. Clinical score for classification of
asthma
4
4
4
7. Value for %ii25 less than 10%
8. Proportion of SAL neutrophils mare than
20%
9. Proportion of SAL eosinophils more than
10%
1. Expectoration mare than 100 .01 a day
2. Expectoration between 50-99 .01 a day
3. Presence of sputum in many areas of
the airways an auscultation
4. Day-lang difficulty of expectoration
5. Transient bubbling rales in bath lower
lung fields an auscultation
6. Alveolar breath sounds in bath lower lung 4
fields markedly decreased or disappeared
an auscultation
examinations!5). The criteria for this classifi-
cation system is shown is Table 2. Asthma
classification by a score is almost same to
classification by clinical symptoms, since a
score calculated from each finding and
examinationfon is specific for each clinical
asthma type; marked increase of BAL eosino-
phils IS specific for I b. bronchoconstric-
tion +hypersecretion type, and BAL neutro-
Asthma classification can be performed by
a score calculated from clinical findings and
Score diagnosis
(p<O.OOl), and type lb (p<O.OOl), as shown
in Fig. 2. Decreased proportion of BAL
lymphocytes and increased proportion of BAL
neutrophils, which are often observed III
asthma patients with long-term glucocor-
ticoid therapy, are found in type IT asthma.
Ventilatory funchion IS also related to
clinical asthma type. The values of parame-
.
ters such as FEV 1.0 % and % V25 showing
obstructive ventilatory dysfunction markedly
decrease III type IT asthma, particuarly,
marked decrease in % V25 value representing
ventilatory dysfunction of small aIrways.
This is characteristic of type IT asthma with
BAL neutrophilia (Fig. 3).
These results demonstrate that increased
number of BAL neutrophils and marked
decrease III % V25 value closely correlates
with pathophysiological changes of the air-
ways of type IT asthma.
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.
philiaIB. 19) and marked decerease In % V25
value for type II, bronchiolar obustruction
type of asthma.
Type II asthma with BAL neutrophilia
As shown in Fig. 2, BAL neutrophilia IS
often found in type II asthma. In this type
of asthma, marked decrease in number of
BAL lymphocytes is also observed20). The
increased number of BAL neutrophils related
to decreased number of BAL lymphocytes is
observed in some of patients with long-term
glucocorticoid therepylB.19.21), in whom, In
addition to decrease in number of BAL and
peripheral lymphocytes, suppressed humoral
and cellular immunity is found. Thus, it has
been suggested that suppressed immunity
leads to BAL neutrophilia, which is major
feature of type II asthma.
Type II asthma without BAL neutrophilia
It has been shown that BAL neutrophilia is
a common feature of type II asthma l 2-15),
However, our recent studies have demon-
strated that type II asthma without BAL
neutrophilia is present when classification is
performed by clinical symptoms (clinical
diagnosis), not by clinical findings and ex-
aminations (score diagnosis)15). This type of
asthma is not related to suppressed immu-
nity, and severity of their symptoms is not
so marked as that of same type with BAL
neutrophilia. The onset mechanisms of type
II asthma without BAL neutrophilia is not
clear. However, it has been speculated that
one of factors leading to this type of asthma
is aging, since mean age of this type of
asthma is higher than age of same type with
BAL neutrophilia. Other causes inducing type
II asthme without BAL neutrophilia should
be analyzed by further studies of asthma.
Conclusion
It has been suggested that there are two
kinds of type II, bronchiolar obstruction,
asthma with and without BAL neutrophilia
when asthma is classified by clinical symp-
toms. The pathogensis of type II asthma
with BAL neutrophilia is closely related to
suppressed immunity. In contrast, pathogene-
sis inducing type II asthma without BAL
neutrophilia is not clear. It has been specu-
lated that one of factors causing this type of
asthma is aging.
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Ⅱ型鴨息 (細気管支閉塞型)と気管支肺胞洗浄液
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気管支職息は,その臨床症状より,ia型
(Ia-1およびIa-2),ib型およびⅢ型の3
つの病型に分けることができる (臨床分類)｡ま
た,同時に臨床所見および検査により分類するこ
とができる (スコア-分類)｡いずれの分類にお
いても,BAL液中の好中球の著増および高度な
%V25値の低下がⅡ細気管支閉塞型の特徴的所
見である｡しかしながら,BAL液中の好中球の
増加をともなわないⅡ型瑞息が存在することが明
らかにされている｡これらの症例では,BAL液
中好中球増加をともなう症例に比べ平均年齢が高
い｡しかし,FEVl.0%値､BAL液中リンパ球頻
度や血清IgG値などは､好中球増加をともなう
症例はどの低下傾向は見られない｡これらの結果
はBAL液中好中球増加をともなうⅡ型喋息の発
症機序には､液性および細胞性免疫能の低下が､
また､BAL液中好中球増加をともなわないⅢ型
喋息では､加齢がある程度関連していることを示
している｡
キーワード,'瑞息分類,正型瑞息,BALリンパ●
球,BAL好中球,%V25
